48
Participants
Start Date
January 31, 2026
Primary Completion Date
February 29, 2028
Study Completion Date
June 30, 2028
Hemanext ONE System
Hypoxic red blood cells
Conventional RBCs
Conventional red blood cells
University of Pittsburgh, Pittsburgh
University of Pittsburgh Medical Center, Pittsburgh
John Hopkins University School of Medicine, Baltimore
Emory University School of Medicine, Atlanta
Johns Hopkins All Children's Hospital, St. Petersburg
New England Sickle Cell Institute, University of Connecticut, Farmington
Lead Sponsor
Emory University
OTHER
University of Connecticut
OTHER
University of Pittsburgh Medical Center
OTHER
Johns Hopkins All Children's Hospital
OTHER
Johns Hopkins University
OTHER
Hemanext
INDUSTRY